Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

313329

Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

Repeat injections of mesenchymal stem cells (MSCs) into the spinal canal were safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), and showed a potential to significantly slow the rate of disease progression, a small Phase 2 clinical trial found. “Larger studies are warranted to confirm our observations and further evaluate the therapeutic potential of cellular therapy in neurodegenerative diseases such as ALS,” the researchers wrote. The study, “A phase II clinical trial…

You must be logged in to read/download the full post.